Fabian Jimenez Contreras

Fabian Jimenez Contreras

Auto-generated profile, based on publicly available information

Fabian Jimenez Contreras

Department of Surgery, Division of Thoracic and Cardiovascular Surgery University of Florida Gainesville Florida USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2025 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
AHAbanob George Hanna
Abanob George Hanna
FCFabian Jimenez Contreras
Fabian Jimenez Contreras
OSOmar M. Sharaf
Omar M. Sharaf
GSGriffin P. Stinson
Griffin P. Stinson
PHPhilip J. Hess
Philip J. Hess
Purpose: Aortic dissections and repairs are associated with high rates of mortality. The aim of this review is to summarize the literature concerning the prognostic ability of various preoperative biomarkers for patients undergoing surgical repair of the thoracic and abdominal aorta to elucidate whether these biomarkers could improve the selection of surgical candidates. Methods: Relevant biomarkers were selected if they had predictive value in inflammatory disease processes and/or cardiovascular disease. Full-text articles available in English on PubMed that related these biomarkers to the prognosis of aortic repair following aortic dissection were examined. Results: For patients who underwent repair for type A dissection, a preoperative elevated SII was associated with inferior 30-day survival (hazard ratio: 3.532, 95% confidence interval: 1.719–7.255, p = 0.001) and increased rates of adverse cardiovascular events. Elevated preoperative IL-6 and D-dimer levels were independently associated with single-organ dysfunction, multiorgan dysfunction, and death. The use of a combination of markers was a stronger predictor. The areas under the curve (AUCs) for the specified IL-6 and D-dimer cutoff values were 0.901 and 0.817, respectively, whereas the AUC reached 0.936 when IL-6 was combined with D-dimer. For patients who underwent thoracic endovascular aortic repair (TEVAR) for type B dissection, an elevated postoperative systemic immune-inflammation index (SII) was an independent risk factor for aorta-related complications, graft failure, and significantly inferior freedom from aortic-related mortality. A combination of elevated preoperative and postoperative SII values was again predictive of in-hospital adverse outcomes and follow-up complications, including endoleaks, branch artery stenosis, distal aortic expansion, aortic rupture, and death (p = 0.0016). An elevated preoperative neutrophil‒leukocyte ratio (NLR) is associated with an increased incidence of early postoperative adverse events and poor survival. Conclusions: Inflammatory markers seem to have predictive ability for postoperative outcomes after aortic repair in type A dissections. Further studies should compare these biomarkers to determine the best predictive marker for individual disease states and surgeries.

15 February 2022 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
FCFabian Jimenez Contreras
Fabian Jimenez Contreras
MPMichelle Mendiola Pla
Michelle Mendiola Pla
JSJacob Schroder
Jacob Schroder
BBBenjamin Bryner
Benjamin Bryner
RARicha Agarwal
Richa Agarwal
CMCarmelo Milano
Carmelo Milano
OBJECTIVES: Long-term left ventricular assist device (LVAD) support can cause accelerated progression of aortic insufficiency (AI). The MOMENTUM trial has led to increased use of the HeartMate 3 (HM3) LVAD, due to greater hemocompatibility. However, the differential effect on the rate of progression of AI during HM3 support versus HeartMate 2 (HM2) has not been extensively studied. This analysis compares the rates of progression to moderate or severe AI (MSAI) comparing a cohort of patients supported with the HM2 versus HM3. METHODS: A retrospective review was performed on all consecutive patients implanted with HM2 or HM3 between May 2005 and June 2020. Follow-up time was limited to the first 6 years after LVAD implantation. Demographics and 4005 echocardiograms were assessed for 536 HM2 and 300 HM3 patients. The primary end point was progression to MSAI. Univariable and multivariable Cox proportional hazard regression and landmark analyses were performed. RESULTS: Progression to MSAI was greater in the HM2 (17%) versus HM3 (9.9%) cohort. On the univariable analysis, the hazard ratio for HM3 was 0.581 (95% confidence interval 0.370–0.909, P = 0.02) whereas on multivariable analysis hazard ratio was 0.624 (95% confidence interval 0.386–1.008, P = 0.0537). Preoperative AI, female sex and body surface area <2 were significantly associated with progression to MSAI. Landmark analysis suggests that LVAD type has the most significant effect on progression to MSAI between 1 and 2 years post-implantation. CONCLUSIONS: Current practice strategies achieved low rates of progression to MSAI. Preoperative AI, female sex and body surface area <2 were the most important predictors of progression to MSAI. Pump type appears to be of secondary importance.

16 May 2025 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
ABAhmet Bilgili
Ahmet Bilgili
IWIverson Williams
Iverson Williams
OSOmar M Sharaf
Omar M Sharaf
FCFabian Jimenez Contreras
Fabian Jimenez Contreras
YSYuriy Stukov
Yuriy Stukov
EJEric Jeng
Eric Jeng

9 April 2024 in JTCVS Open
Verified
Journal Article
Open access
FCFabian Jimenez Contreras
Fabian Jimenez Contreras
BPBret L. Pinsker
Bret L. Pinsker
JKJason N. Katz
Jason N. Katz
SRStuart D. Russell
Stuart D. Russell
JSJacob Schroder
Jacob Schroder
CMCarmelo Milano
Carmelo Milano
There is a paucity of data assessing the impact of nutritional status on outcomes in patients supported with the HeartMate 3 (HM3) left ventricular assist device (LVAD). Patients ≥18 years of age who underwent HM3 LVAD implantation between 2015 and 2020 were identified from a single tertiary care center. The primary outcome assessed was death or device replacement. A secondary outcome of driveline infection was also evaluated. Kaplan-Meier survival analysis and a multivariate Cox-proportional hazards model were used to identify predictors of outcome. Of the 289 patients identified, 94 (33%) experienced a primary outcome and 96 (33%) a secondary outcome during a median follow-up time of 2.3 years. Independent predictors of the primary outcome included peripheral vascular disease (hazard ratio [HR], 3.40; 95% confidence interval [CI], 1.66-6.97, P < .01), diabetes mellitus (HR, 0.46; 95% CI, 0.27-0.80, P < .01), body mass index ≥40 kg/m2 (HR, 2.63 per 1 kg/m2 increase; 95% CI, 1.22-5.70, P < .05), preoperative creatinine level (HR, 1.86 per 1 mg/dL increase; 95% CI, 1.31-2.65, P < .01), and preoperative prognostic nutritional index (PNI) score (HR, 0.88 per 1-point increase; 95% CI, 0.81-0.96, P < .01). Independent predictors of driveline infection included age at the time of implantation (HR, 0.97; 95% CI, 0.96-0.99, P < .01) and diabetes mellitus (HR, 1.79; 95% CI, 1.17-2.73, P < .01). Preoperative PNI scores may independently predict mortality and the need for device replacement in patients with HM3 LVAD. Routine use of the PNI score during preoperative evaluation and, when possible, supplementation to PNI >33, may be of value in this population.

10 October 2023 in Artificial Organs
Verified
Journal Article
Closed access
FCFabian Jimenez Contreras
Fabian Jimenez Contreras
JRJess David Rames
Jess David Rames
JSJacob Schroder
Jacob Schroder
SRStuart D. Russell
Stuart D. Russell
JKJason Katz
Jason Katz
CMCarmelo Milano
Carmelo Milano

1 March 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
FCFabian Jimenez Contreras
Fabian Jimenez Contreras
OJOliver K. Jawitz
Oliver K. Jawitz
VRVignesh Raman
Vignesh Raman
ACAshley Y. Choi
Ashley Y. Choi
MHMatthew G. Hartwig
Matthew G. Hartwig
JKJacob A. Klapper
Jacob A. Klapper